Price
Target price
€1.30
€1.30
3.170%
0.04
3.170%
-
20.05.24 / Stuttgart Stock Exchange
WKN: A119KH / Name: Enlivex Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Enlivex Therapeutics Ltd. Stock
Enlivex Therapeutics Ltd. dominated the market today, gaining €0.040 (3.170%).
Our community identified positive and negative aspects for Enlivex Therapeutics Ltd. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Enlivex Therapeutics Ltd. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Enlivex Therapeutics Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enlivex Therapeutics Ltd. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enlivex Therapeutics Ltd. | 3.170% | -5.109% | 2.362% | -48.000% | -41.964% | -83.117% | - |
Oramed Pharmaceuticals | -1.100% | -2.769% | 2.834% | -47.441% | 2.883% | -75.811% | -21.380% |
Galmed Pharmaceuticals Ltd. | -2.150% | 1.667% | 3.977% | -92.146% | -16.055% | - | - |
Evolus Inc | -1.630% | 4.310% | 14.151% | 34.444% | 33.702% | 59.211% | - |